comparemela.com

Shaq Vayda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Siren Biotechnology Launches to Pioneer Universal AAV

Novel approach combines the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single.

Salk instituteUnited statesSan franciscoShaq vaydaNicole paulkLiz meloneLos angelesKaye sprattSharon tetlowScott nolanSusan kaechBeverly davidsonFounders fundPartner at founders fundPaulk labUniversity of california

TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study

"Growth at all costs" is a fairy tale made possible by cheap money that helped VCs set expectations for founders and each other.

United statesWalter thompsonBryce durbin techcrunchFranck lescureAnna heimHeather gantt evansSteve goldbergAngelina lipartelianiShaq vaydaRebecca mitchemFrancisco dopazoJames coatesSarah guoRobert mittendorffHumboldt fundNeotribes ventures

As AI pervades biotech, what are investors looking for in 2023?

Six investors we surveyed recently told us that the macro environment has had a big impact on deal flow, valuations and M&A in biotech.

Francisco dopazoFranck lescureSarah guoJames coatesRobert mittendorffShaq vaydaJp morganHumboldt fundSilicon valleyBig pharmaLux capitalElaia partners

6 investors discuss why AI is more than just a buzzword in biotech

To get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today.

United statesChris meierFrancisco dopazoFranck lescureSarah guoJames coatesRobert mittendorffShaq vaydaWatson healthHumboldt fundBoston consulting groupElaia partnersLux capitalConsulting groupNature reviews drug discoveryBig pharma

vimarsana © 2020. All Rights Reserved.